| Literature DB >> 18097000 |
Carolyn G King1, Jodi L Buckler, Takashi Kobayashi, Jeffrey R Hannah, Garrett Bassett, Taesoo Kim, Erika L Pearce, Gregory G Kim, Laurence A Turka, Yongwon Choi.
Abstract
TRAF6, TNFR-associated factor 6, is a key adaptor downstream from the TNF receptor and TLR superfamily members. T cell-specific deletion of TRAF6 (TRAF6-DeltaT) was recently shown to result in the development of multiorgan inflammatory disease and the resistance of responder T cells to suppression by CD4+CD25+ regulatory T cells. In this study we examined the role of TRAF6 in an additional mechanism of peripheral tolerance, anergy. We have determined that the loss of TRAF6 restores the ability of CD28-/- T cells to proliferate and produce IL-2. Consistent with this, TRAF6-DeltaT T cells were resistant to anergizing signals both in vitro and in vivo. Resistance to anergy was correlated with decreased expression of Cbl-b. These findings reveal that in addition to its role in rendering T cells susceptible to control by CD4+CD25+ regulatory T cells, TRAF6 is essential for the induction of T cell anergy, implicating TRAF6 as a critical mediator of peripheral tolerance.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18097000 DOI: 10.4049/jimmunol.180.1.34
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422